Last reviewed · How we verify
NCT06916780: DSM
Elhafez Technique Combined With Dynamic Scapulohumeral Mobilization in Shoulder Adhesive Capsulitis
NA trial testing Laser and ultrasound in Adhesive Capsulitis of the Shoulder in 90 participants. Suspended.
1 July 2025
Quick facts
| Lead sponsor | Haytham M Elhafez |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 9 April 2025 |
| Primary completion | 1 July 2025 |
| Estimated completion | 30 August 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Laser and ultrasound
Conditions studied
- Adhesive Capsulitis of the Shoulder — all drugs for Adhesive Capsulitis of the Shoulder →
Sponsor
Haytham M Elhafez
Who can join
Adults 30 to 60, any sex, with Adhesive Capsulitis of the Shoulder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Elhafez Technique Combined with Dynamic Scapulohumeral Mobilization in Adhesive Capsulitis
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06916780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adhesive Capsulitis of the Shoulder
Currently open trials in the same condition.
- NCT07336849 — Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment · NA · recruiting
- NCT07097571 — Suprascapular Nerve Block in the Management of Patients Diagnosed With Adhesive Capsulitis · NA · active not recruiting
- NCT06848374 — Dose Efficacy in Adhesive Capsulitis · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06916780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Haytham M Elhafez
- Last refreshed: 13 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06916780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing